Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa.
<h4>Background</h4>Treatment-related outcomes in patients with extensively drug-resistant tuberculosis (XDR-TB) are poor. However, data about the type, frequency and severity of presumed drug-associated adverse events (AEs) and their association with treatment-related outcomes in patient...
Main Authors: | Karen Shean, Elizabeth Streicher, Elize Pieterson, Greg Symons, Richard van Zyl Smit, Grant Theron, Rannakoe Lehloenya, Xavier Padanilam, Paul Wilcox, Tommie C Victor, Paul van Helden, Martin P Grobusch, Robin Warren, Motasim Badri, Keertan Dheda |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23667572/pdf/?tool=EBI |
Similar Items
-
Correction: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa
by: Karen Shean, et al.
Published: (2013-01-01) -
Correction: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa.
by: Karen Shean, et al.
Published: (2013-01-01) -
What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?
by: Anil Pooran, et al.
Published: (2013-01-01) -
High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosis.
by: Elize Pietersen, et al.
Published: (2015-01-01) -
Early treatment outcomes of patients with extensively drug resistant tuberculosis in South Africa
by: S. Janssen, et al.
Published: (2014-04-01)